Cargando…
Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
Given the median survival of 15 months after diagnosis, novel treatment strategies are needed for glioblastoma. Beta-blockers have been demonstrated to inhibit angiogenesis and tumor cell proliferation in various cancer types. The aim of this study was to systematically review the evidence on the ef...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035104/ https://www.ncbi.nlm.nih.gov/pubmed/32172480 http://dx.doi.org/10.1007/s10143-020-01277-4 |